Table 1.
Main characteristics of the studies included in this meta-analysis
Author | Year | Language | Treatment arms | n | Male | Age | Follow-up (days) |
Schumacher et al30 | 2002 | English | Etoricoxib 120 mg one time a day | 75 | 73 | 48.5 (13.29) | 8 |
Indomethacin 50 mg three times a day | 75 | 69 | 49.5 (13.71) | ||||
Rubin et al31 | 2004 | English | Etoricoxib 120 mg one time a day | 103 | 98 | 51.1 (13) | 8 |
Indomethacin 50 mg three times a day | 86 | 79 | 52.2 (12) | ||||
Ye et al32 | 2010 | Chinese | Etoricoxib 120 mg one time a day | 40 | 33 | 45.12 (12.48) | 7 |
Diclofenac 75 mg one time a day | 35 | 32 | 38.20 (15.51) | ||||
Zhang et al20 | 2012 | Chinese | Etoricoxib 120 mg one time a day | 48 | 48 | 63.4 (12) | 8 |
Meloxicam 15 mg one time a day | 36 | 36 | 64.1 (11) | ||||
Gao and Pang33 | 2013 | Chinese | Etoricoxib 120 mg one time a day | 140 | 89 | 41.78 (12.57) | 7 |
Diclofenac 75 mg two times per day | 140 | 92 | 42.48 (13.23) | ||||
Hong and Xu21 | 2013 | Chinese | Etoricoxib 120 mg one time a day | 50 | 38 | 42.1 (9.8) | 7 |
Celecoxib 200 mg three times a day | 50 | 40 | 41.5 (7.8) | ||||
Li et al34 | 2013 | English | Etoricoxib 120 mg one time a day | 89 | 85 | 52 (15) | 5 |
Indomethacin 75 mg two times per day | 89 | 81 | 53 (14) | ||||
Guo et al18 | 2014 | Chinese | Etoricoxib 120 mg one time a day | 60 | 96 | 44.3 (15.6) | 8 |
Meloxicam 15 mg one time a day | 60 | ||||||
Guo et al35 | 2014 | Chinese | Etoricoxib 120 mg one time a day | 57 | 56 | 40.52 (11.27) | 5 |
Diclofenac 75 mg one time a day | 56 | 54 | 43.03 (13.02) | ||||
Lu36 | 2014 | Chinese | Etoricoxib 120 mg one time a day | 95 | 89 | 48.9 (2.3) | 7 |
Diclofenac 50 mg three times a day | 51 | 49 | 46.7 (3.4) | ||||
Kuang37 | 2015 | Chinese | Etoricoxib 120 mg one time a day | 40 | 29 | 42.8 (10.3) | 7 |
Diclofenac 50 mg three times a day | 40 | 31 | 43.7 (11.2) | ||||
Liu17 | 2015 | Chinese | Etoricoxib 120 mg one time a day | 32 | 21 | 45 (3.74) | 7 |
Meloxicam 15 mg one time a day | 32 | 13 | 44 (3.53) | ||||
Xia22 | 2015 | Chinese | Etoricoxib 120 mg one time a day | 40 | 27 | 50.17 (25.13) | 7 |
Celecoxib 200 mg three times a day | 40 | 25 | 50.09 (25.34) | ||||
Zhu38 | 2015 | Chinese | Etoricoxib 120 mg one time a day | 50 | 48 | 46.3 (6.9) | 7 |
Diclofenac 50 mg three times a day | 50 | 49 | 46.5 (6.1) | ||||
Cui and Liu15 | 2016 | Chinese | Diclofenac 100 mg one time a day | 12 | 11 | 41.5 (3.8) | 5 |
Celecoxib 200 mg one time a day | 12 | 10 | 43.2 (4.2) | ||||
Li et al39 | 2016 | Chinese | Etoricoxib 120 mg one time a day | 47 | 22 | 41.8 (11.3) | 5 |
Diclofenac 75 mg one time a day | 47 | 21 | 40.5 (10.1) | ||||
Ming24 | 2016 | Chinese | Etoricoxib 120 mg one time a day | 38 | 22 | 52.64 (12.28) | 7 |
Celecoxib 200 mg two times per day | 38 | 23 | 52.79 (12.35) | ||||
Pan and Chen40 | 2016 | Chinese | Etoricoxib 120 mg one time a day | 68 | 126 | 43.2 (13.6) | 7 |
Diclofenac 50 mg three times a day | 68 | ||||||
Zhou23 | 2016 | Chinese | Etoricoxib 120 mg one time a day | 28 | 16 | 53.37 (11.32) | 7 |
Celecoxib 200 mg three times a day | 28 | 14 | 52.13 (10.13) | ||||
Li et al19 | 2017 | Chinese | Etoricoxib 120 mg one time a day | 44 | 68 | 44.67 (14.99) | 8 |
Meloxicam 15 mg one time a day | 44 | ||||||
Gao and Yang41 | 2018 | Chinese | Celecoxib 200 mg two times per day | 40 | 29 | 58.4 (2. 8) | 7 |
Etoricoxib 120 mg one time a day | 40 | 30 | 56.7 (2. 2) | ||||
Lan et al42 | 2018 | Chinese | Celecoxib 200 mg two times per day | 30 | 24 | 52.21 (1.25) | 7 |
Etoricoxib 120 mg one time a day | 30 | 25 | 52.26 (1.24) | ||||
Sheng43 | 2019 | Chinese | Etoricoxib 120 mg one time a day | 42 | 82 | 39.17 (10.28) | 7 |
Diclofenac 75 mg one time a day | 38 | ||||||
Wu and Yang44 | 2019 | Chinese | Etoricoxib 120 mg one time a day | 30 | 23 | 45.98 (6.65) | 7 |
Meloxicam 15 mg one time a day | 30 | 21 | 45.21 (7.20) |
Age presented as mean (SD).